Gastrointestinal Cancer News

Incidence of cervical cancer declined as rates of other HPV-associated cancers increased significantly in the U.S. from 2001 to 2017, according to a population-based study of trends presented during the virtual ASCO Annual Meeting.

The FDA approved nivolumab as adjuvant treatment for certain patients with completely resected esophageal or gastroesophageal junction cancers, according to the agent’s manufacturer.

Despite historic lows in smoking prevalence, rates of cancer prevention and early detection remained suboptimal in the U.S. between 2018 and 2019, according to a study by researchers at American Cancer Society.

Patients with cancer who resided in states with lower Medicaid income eligibility limits had poorer long-term survival rates than patients in states with higher limits, according to a study presented during the virtual ASCO Annual Meeting.

The U.S. Preventive Services Task Force issued updated recommendations for colorectal cancer screening in JAMA.

American Institute for Cancer Research awarded more than $1 million worth of grants to fund research designed to improve understanding of how diet, nutrition, physical activity and body weight affect cancer prevention and survivorship.

The issue of racial and ethnic disparities in health care has moved to the forefront of the medical community and has been further underscored by differences in COVID-19 vaccination rates.

Progress in the non-endoscopic detection for Barrett’s esophagus may lead to increased identification of those at risk for esophageal adenocarcinoma, according to opinions published in Annals of Internal Medicine.

Although patients in underrepresented groups present with worse outcomes than white patients, pancreatic cancer trials fail to represent non-white patients, according to a presentation at Digestive Diseases Week.

Jordan Anaokar, MD, has been appointed site director for radiology at Fox Chase Cancer Center.